NK-1 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF EYE DISORDERS - Patent 0790825

(19)

(11)

EP 0 790 825 A1

(12)

(43)	Date of publication:
	27.08.1997 Bulletin 1997/35

(21)	Application number: 95931373.0

(22)	Date of filing: 29.09.1995

(51)

International Patent Classification (IPC):

A61K 31/ 135^{( . )}
A61K 31/ 40^{( . )}
A61K 31/ 451^{( . )}
A61K 31/ 454^{( . )}
A61K 31/ 675^{( . )}
A61P 27/ 06^{( . )}

A61K 31/ 137^{( . )}
A61K 31/ 438^{( . )}
A61K 31/ 4535^{( . )}
A61K 31/ 55^{( . )}
A61P 27/ 02^{( . )}
A61P 43/ 00^{( . )}

(86)	International application number:
	PCT/IB1995/000811

(87)	International publication number:
	WO 1996/014845 (23.05.1996 Gazette 1996/23)

(84)	Designated Contracting States:
	AT BE CH DE DK ES FR GB GR IE IT LI LU NL PT SE

(30)

Priority:

10.11.1994 US 19940336955

(71)	Applicant: PFIZER INC.
	New York, N.Y. 10017 (US)

(72)	Inventor:
	HESS, Hans-Jurgen Ernst Old Lyme, CT 06371 (US)

(74)	Representative: Ruddock, Keith Stephen, et al
	Pfizer Limited, European Patent Department, Ramsgate Road Sandwich, Kent CT13 9NJ Sandwich, Kent CT13 9NJ (GB)

(54)	NK-1 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF EYE DISORDERS